Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Sigyn Therapeutics Inc (SIGY)

Sigyn Therapeutics Inc (SIGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange Globe Newswire - Wed Aug 3, 2022

SAN DIEGO, CA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage medical technology...

OTC.VN : 0.300 (unch)
SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board Globe Newswire - Thu Mar 31, 2022

SAN DIEGO, CA, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics™ Appoints H. David Humes, MD to Its Scientific Advisory Board Globe Newswire - Tue Mar 15, 2022

SAN DIEGO, CA, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics to Present at the Bullseye Small Cap Virtual Investor Conference Globe Newswire - Tue Jan 25, 2022

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics Announces Presentation at Today’s Emerging Growth Conference Globe Newswire - Wed Jan 5, 2022

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets: “SIGY”), a medical technology company focused on...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or Vaccines Globe Newswire - Fri Dec 17, 2021

SAN DIEGO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis Globe Newswire - Wed Dec 1, 2021

In the Past Year, Sigyn Therapy™ Has Been Validated to Address a Broad-Spectrum of Inflammatory Mediators, Gram-Negative Bacterial Toxins, Gram-Positive...

SIGY : 5.0000 (-4.76%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies Investor Brand Network - Mon Nov 15, 2021

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 2.84 (-3.73%)
ATNM : 8.81 (-0.34%)
ADCO.TO : 0.2300 (-6.12%)
ADCOF : 0.1600 (-11.11%)
ALIM : 3.57 (-4.80%)
ACOGF : 0.4714 (-7.57%)
AMST : 3.14 (+0.32%)
ANVS : 5.35 (-0.74%)
ANPC : 4.37 (-5.41%)
ARC : 2.67 (-2.91%)
Sigyn Therapeutics Featured on National Public Radio: “Addressing the Cytokine Storm” Globe NewsWire - Mon Aug 30, 2021

SAN DIEGO, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...

SIGY : 5.0000 (-4.76%)
Sigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets Globe NewsWire - Tue Aug 10, 2021

SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY ), a medical technology company focused on the treatment of sepsis and other life-threatening...

SIGY : 5.0000 (-4.76%)

Barchart Exclusives

Is It Too Soon to Buy Beaten-Down Peloton Stock? Barchart - 1 hour ago
PTON is in focus amid a fresh round of buyout chatter, but is it worth buying this former pandemic-era standout for the potential Hail Mary upside? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot